ArriVent BioPharma (AVBP) IPO deck
ArriVent Biopharma, Inc. is a privately-held biotechnology company that develops and commercializes targeted cancer therapies.
![](/content/images/size/w1304/2024/01/AVBP_01-1.png)
ArriVent Biopharma, Inc. is a privately-held biotechnology company that develops and commercializes targeted cancer therapies.